257 related articles for article (PubMed ID: 32198945)
1. Apremilast in benign chronic pemphigus (Hailey-Hailey disease).
Riquelme-Mc Loughlin C; Iranzo P; Mascaró JM
Clin Exp Dermatol; 2020 Aug; 45(6):737-739. PubMed ID: 32198945
[No Abstract] [Full Text] [Related]
2. Successful treatment of refractory Hailey-Hailey disease with apremilast.
Di Altobrando A; Sacchelli L; Patrizi A; Bardazzi F
Clin Exp Dermatol; 2020 Jul; 45(5):604-605. PubMed ID: 31930532
[No Abstract] [Full Text] [Related]
3. Treatment of Severe Hailey-Hailey Disease With Apremilast.
Kieffer J; Le Duff F; Montaudié H; Chiaverini C; Lacour JP; Passeron T
JAMA Dermatol; 2018 Dec; 154(12):1453-1456. PubMed ID: 30304341
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of apremilast through 104 weeks in patients with moderate to severe psoriasis who continued on apremilast or switched from etanercept treatment: findings from the LIBERATE study.
Reich K; Gooderham M; Bewley A; Green L; Soung J; Petric R; Marcsisin J; Cirulli J; Chen R; Piguet V
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):397-402. PubMed ID: 29220542
[TBL] [Abstract][Full Text] [Related]
5. Combination of dermabrasion and Apremilast for Hailey-Hailey disease.
Siliquini N; Deboli T; Marchetti Cautela J; Mangia A; Fraccalvieri M; Dapavo P; Quaglino P; Ribero S
Ital J Dermatol Venerol; 2021 Dec; 156(6):727-728. PubMed ID: 32129590
[No Abstract] [Full Text] [Related]
6. Apremilast in combination with botulinum toxin-A injection for recalcitrant Hailey-Hailey disease.
Antoñanzas J; Tomás-Velázquez A; Rodríguez-Garijo N; Estenaga Á; Salido-Vallejo R
Int J Dermatol; 2022 May; 61(5):600-602. PubMed ID: 34705274
[No Abstract] [Full Text] [Related]
7. Improvement of 11 patients with nail psoriasis with apremilast: Results of an investigator-initiated open-label study.
Oak ASW; Ho-Pham H; Elewski BE
J Am Acad Dermatol; 2020 Dec; 83(6):1830-1832. PubMed ID: 32446819
[No Abstract] [Full Text] [Related]
8. Two cases of Hailey-Hailey disease effectively treated with apremilast and a review of reported cases.
Yoto A; Makino T; Mizawa M; Matsui Y; Takemoto K; Furukawa F; Kataoka K; Nakano H; Sawamura D; Shimizu T
J Dermatol; 2021 Dec; 48(12):1945-1948. PubMed ID: 34569085
[TBL] [Abstract][Full Text] [Related]
9. Apremilast, an oral phosphodiesterase-4 inhibitor, in the treatment of palmoplantar psoriasis: Results of a pooled analysis from phase II PSOR-005 and phase III Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis (ESTEEM) clinical trials in patients with moderate to severe psoriasis.
Bissonnette R; Pariser DM; Wasel NR; Goncalves J; Day RM; Chen R; Sebastian M
J Am Acad Dermatol; 2016 Jul; 75(1):99-105. PubMed ID: 27021239
[TBL] [Abstract][Full Text] [Related]
10. Ectopic facial Hailey-Hailey disease.
Dajani ZA; Mutasim DF
J Am Acad Dermatol; 2011 Jul; 65(1):223-4. PubMed ID: 21679827
[No Abstract] [Full Text] [Related]
11. Improvement of Nail and Scalp Psoriasis Using Apremilast in Patients With Chronic Psoriasis: Phase 2b and 3, 52-Week Randomized, Placebo-Controlled Trial Results.
Nguyen CM; Leon A; Danesh M; Beroukhim K; Wu JJ; Koo J
J Drugs Dermatol; 2016 Mar; 15(3):272-6. PubMed ID: 26954311
[TBL] [Abstract][Full Text] [Related]
12. Real-World Effectiveness and Safety of Apremilast in Older Patients with Psoriasis.
Phan C; Beneton N; Delaunay J; Reguiai Z; Boulard C; Fougerousse AC; Cinotti E; Romanelli M; Mery-Bossard L; Thomas-Beaulieu D; Parier J; Maccari F; Chaby G; Bastien M; Begon E; Samimi M; Prignano F; Beauchet A; Mahé E;
Drugs Aging; 2020 Sep; 37(9):657-663. PubMed ID: 32696432
[TBL] [Abstract][Full Text] [Related]
13. Apremilast in psoriatic arthritis.
Schett G
Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S98-100. PubMed ID: 26472278
[TBL] [Abstract][Full Text] [Related]
14. Old drug, new tricks - successful treatment of Hailey-Hailey disease with thalidomide.
Kearney N; Raichura S; Houghton J; O'Kane D
Australas J Dermatol; 2021 Feb; 62(1):94-96. PubMed ID: 33070308
[No Abstract] [Full Text] [Related]
15. Drug safety evaluation of apremilast for treating psoriatic arthritis.
Busa S; Kavanaugh A
Expert Opin Drug Saf; 2015 Jun; 14(6):979-85. PubMed ID: 25827658
[TBL] [Abstract][Full Text] [Related]
16. [Tacrolimus--a new therapeutic option for Hailey-Hailey-disease?].
Reuter J; Termeer C; Bruckner-Tuderman L
J Dtsch Dermatol Ges; 2005 Apr; 3(4):278-9. PubMed ID: 16370477
[TBL] [Abstract][Full Text] [Related]
17. Real-World Clinical Experience With Apremilast in a Large US Retrospective Cohort Study of Patients With Moderate to Severe Plaque Psoriasis.
Armstrong A; Levi E
J Drugs Dermatol; 2017 Dec; 16(12):1240-1245. PubMed ID: 29240859
[TBL] [Abstract][Full Text] [Related]
18. A phase 2, open-label, investigator-initiated study to evaluate the safety and efficacy of apremilast in subjects with recalcitrant allergic contact or atopic dermatitis.
Volf EM; Au SC; Dumont N; Scheinman P; Gottlieb AB
J Drugs Dermatol; 2012 Mar; 11(3):341-6. PubMed ID: 22395585
[TBL] [Abstract][Full Text] [Related]
19. Apremilast: A Review in Psoriasis and Psoriatic Arthritis.
Deeks ED
Drugs; 2015 Aug; 75(12):1393-403. PubMed ID: 26220911
[TBL] [Abstract][Full Text] [Related]
20. Chronic tearing induced by apremilast.
Norris MR; Bielory L
Ann Allergy Asthma Immunol; 2018 Sep; 121(3):375. PubMed ID: 29969663
[No Abstract] [Full Text] [Related]
[Next] [New Search]
